Do you want to read an article? Please log in or register.
Looking Beyond Glycaemic Control: Real-World 12-Month Cardiometabolic and Retinopathy Outcomes Following Omnipod 5 Initiation in People With Type 1 Diabetes
Retinal Diseases
Related content
COMMENTED
Retinal Diseases
Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed-Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study-Level Synthesis
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Obes Metab
Anson M, Iqbal A, Azmi S, Weston P, Hughes L, Choudhury M, Hughes DM, Zheng Y, Burgess PI, Alam U
doi: 10.1111/dom.71084
Retinal Diseases
Associations between fenofibrate use and sight-threatening diabetic retinopathy in type 2 diabetes: UK real-world evidence
J Clin Endocrinol Metab
Tan L, Cooper JM, Gokhale K, Sainsbury C, Denniston AK, Toulis KA, Crowe FL, Nirantharakumar K, Wang J
doi: 10.1210/clinem/dgag367
Macular Diseases
Real-World Outcomes after Switch to Aflibercept 8 mg in Neovascular AMD: Twelve Months Follow-up on 654 Eyes
Retina
Lee C, Karunainathan MG, Zohalinejad KD, Mæng MO, Fabrin NW, Yde SK, Wykoff CC, Abildgaard SK, Vorum H, Subhi Y, Ørskov M, Cehofski LJ
doi: 10.1097/IAE.0000000000004888
Macular Diseases
Assessment of real-life visual outcomes and treatment efficacy of diabetic macular edema in patients with type 2 diabetes
BMC Ophthalmol
Konttinen A, Wirkkala J, Kubin AM, Ohtonen P, Hautala N
doi: 10.1186/s12886-026-05083-2
RECOMMENDED
Retinal Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Shah J, Makwana B, Panchal K, Patel V, Patel T, Khadke S, Verma A, Vivekanandan S, Kong Y, Upadhyay J, Dani SS, Ramsey KM, Ganatra S, Ramsey DJ
doi: 10.1016/j.ajo.2026.04.021
Retinal Diseases
Glucagon-like peptide-1 receptor agonists and risk of diabetic retinopathy in type 2 diabetes: A systematic review and network meta-analysis of randomized clinical trials
Surv Ophthalmol
Ortiz-Seller A, Real JT, Morcillo E, Ortiz JL
doi: 10.1016/j.survophthal.2026.08.007
Retinal Diseases
Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial
JAMA Ophthalmol
Sasako T, Ueki K, Miyoshi K, Miyake K, Aoyama T, Okazaki Y, Ishizuka N, Yamauchi T, Noda M, Kadowaki T, J-DOIT3 Study Group
doi: 10.1001/jamaophthalmol.2025.3819
COMMENTED
Macular DiseasesRetinal Diseases
Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Am J Ophthalmol
Murray M, Schifano F, Chiappini S, Corkery JM, Guirguis A
doi: 10.1016/j.ajo.2025.12.015
COMMENTED
Retinal Diseases
Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Ophthalmol Retina
Hong AT, Lin F, Keenan JD, Stewart JM
doi: 10.1016/j.oret.2026.02.002